PODD
InsuletยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PODD Profile
Insulet Corporation
An innovative medical device company that develops wireless, handheld insulin infusion systems for people with insulin-dependent diabetes
Healthcare Equipment and Supplies
--
05/15/2007
NASDAQ Stock Exchange
3,900
12-31
Common stock
100 Nagog Park, Acton, Massachusetts 01720
--
Insulet Corporation is a Delaware corporation established in 2000. The Company is principally engaged in the development, manufacture and sale of its proprietary continuous insulin delivery system for patients with insulin-dependent diabetes mellitus. The Omnipod platform includes: Omnipod 5 Automatic Insulin Delivery System, Omnipod DASH Insulin Management System, Omnipod Insulin Management System and the latest innovative product Omnipod GOTM, licensed by the US Food and Drug Administration in 2023. The company also manufactures Pods for Amgen for use in Neulasta Onpro kits, a delivery system for Amgen's Neulasta that helps reduce the risk of infection after intensive chemotherapy.
